Login
Lantheus Holdings Inc logo

Lantheus Holdings Inc

lantheus.com

Lantheus Holdings Inc (NASDAQ: LNTH) is a radiopharmaceutical company that develops, manufactures, and commercializes diagnostic and therapeutic agents used in medical imaging and targeted oncology. The filing excerpts provided do not contain sufficient detail to characterize revenue streams, segment mix, customer concentration, competitive position, or leadership with the specificity required for a source-grounded description. Based solely on the available filing content, no further claims about revenue model, market position, geographic footprint, or business quality can be supported.

Financial Snapshot

Revenue
TTM
$1.546B
Gross Margin
TTM
60.52%
Net Income
TTM
$279.0M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
282.83%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
1.212B
Cash
2026 Q1
P/E
TTM
23.25
Free Cash Flow
TTM
$377.1M

Stock Price

Loading...
Market Cap: $6.4872 Billion

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support